← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 1, 2005Last known activity
Oct 4, 2023
Timeline
1920s
- Jan 1, 1926
Toray Industries, Inc— Founded
Drugs by trial phase (24 distinct, 21 trials)
Phase 3 (5 own, 0 via acquisition)
Phase 2 (6 own, 0 via acquisition)
Phase 1 (13 own, 0 via acquisition)
Indications
Studied for
- Carcinoma, Renal Cell
- Cholangiocarcinoma
- Crohn Disease
- Fibrosis
- Hepatitis
- Hepatitis A
- Hepatitis C
- Hepatitis C, Chronic
- Hepatitis, Chronic
- Idiopathic Pulmonary Fibrosis
- Kidney Failure, Chronic
- Liver Diseases
- Nephrosclerosis
- Neuralgia
- Neuralgia, Postherpetic
- Peripheral Nervous System Diseases
- Pruritus
- Pulmonary Fibrosis
- Renal Insufficiency
- Renal Insufficiency, Chronic
Recent trials (21)
- NCT06038578Lead sponsorPhase 2Oct 4, 2023
- NCT05423262Lead sponsorPhase 1Jul 6, 2022
- NCT04282590Lead sponsorPhase 2Apr 30, 2020
- NCT03872947Lead sponsorPhase 1Apr 26, 2019
- NCT03727802Lead sponsorPhase 1Nov 28, 2018
- NCT03346330Lead sponsorPhase 1Nov 30, 2017
- NCT02990481Lead sponsorPhase 1Feb 23, 2017
- NCT03043248Lead sponsorPhase 1Feb 6, 2017
- NCT03002233Lead sponsorPhase 1Nov 1, 2016
- NCT02701374Lead sponsorPhase 2Mar 1, 2016
- NCT01753570CollaboratorPhase 3Dec 1, 2012
- NCT01660243Lead sponsorPhase 2Sep 1, 2012
- NCT01423435CollaboratorPhase 1Aug 1, 2011
- NCT01443429Lead sponsorPhase 1Aug 1, 2011
- NCT01345799Lead sponsorPhase 2Apr 1, 2011
Details
- Founded
- Tokyo, JP Jan 1, 1926
- Last known activity
- Oct 4, 2023